Table 1.

Patient and Disease Characteristics

Characteristics	n = 62
Age, median (range), y	69 (52–84)
KPS (n = 57), median, range*	90 (70–100)
Measurable disease, no. of patients (%)	27 (44)
Prior therapies, no. of patients (%)
Surgery	33 (53)
Radiation	37 (60)
Any chemotherapy	35 (56)
Taxane-based chemotherapy	33 (53)
Hormone therapy	62 (100)
Baseline laboratory parameters
Albumin (g/L), median (range)	41 (31–48)
Alkaline phosphatase (units/L), median (range)	121 (38–836)
Hemoglobin (g/dL), median (range)	131 (111–144)
LDH (units/L), median (range)	201.5 (108–700)
PSA (ng/mL), median (range)	56.8 (3.7–5241)

KPS = Karnofsky Performance Status; LDH = lactate dehydrogenase; PSA = prostate-specific antigen.